1,046 results on '"Wei, Yu-Quan"'
Search Results
2. Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets
3. Targeted and immuno-based therapies in sarcoma: mechanisms and advances in clinical trials
4. The approved gene therapy drugs worldwide: from 1998 to 2019
5. Chimeric Antigen Receptor-T Cell Therapy Decreases Distant Metastasis and Inhibits Local Recurrence Post-surgery in Mice
6. Potential roles and targeted therapy of the CXCLs/CXCR2 axis in cancer and inflammatory diseases
7. Surgical Treatment of Osteosarcoma Induced Distant Pre‐Metastatic Niche in Lung to Facilitate the Colonization of Circulating Tumor Cells
8. Targeting Myeloid-derived Suppressor Cells and Programmed Death Ligand 1 Confers Therapeutic Advantage of Ablative Hypofractionated Radiation Therapy Compared With Conventional Fractionated Radiation Therapy
9. Structural optimization and structure-activity relationship studies of N-phenyl-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazin-4-amine derivatives as a new class of inhibitors of RET and its drug resistance mutants
10. TesG is a type I secretion effector of Pseudomonas aeruginosa that suppresses the host immune response during chronic infection
11. Long non-coding RNA AFAP1-AS1 plays an oncogenic role in promoting cell migration in non-small cell lung cancer
12. Synthesis, biological evaluation and molecular docking study of N-(2-methoxyphenyl)-6-((4-nitrophenyl)sulfonyl)benzamide derivatives as potent HIV-1 Vif antagonists
13. Announcing Molecular Biomedicine
14. Immunogene Therapy of Tumors with Vaccine Based on Xenopus Homologous Vascular Endothelial Growth Factor as a Model Antigen
15. Immunopathology of Hepatobiliary Tumors and Immunotherapy of Liver Cancers
16. Pin1 impairs microRNA biogenesis by mediating conformation change of XPO5 in hepatocellular carcinoma
17. Supplementary Tables S1-S4; Supplementary Figures S1-S5; and Supplementary Methods and Figure Legends from Preclinical Evaluation of a Novel Orally Available SRC/Raf/VEGFR2 Inhibitor, SKLB646, in the Treatment of Triple-Negative Breast Cancer
18. Supplementary Methods, Tables 1-4, Figures 1-4 from SKLB1206, a Novel Orally Available Multikinase Inhibitor Targeting EGFR Activating and T790M Mutants, ErbB2, ErbB4, and VEGFR2, Displays Potent Antitumor Activity Both In Vitro and In Vivo
19. Data from Preclinical Evaluation of a Novel Orally Available SRC/Raf/VEGFR2 Inhibitor, SKLB646, in the Treatment of Triple-Negative Breast Cancer
20. Data from SKLB1206, a Novel Orally Available Multikinase Inhibitor Targeting EGFR Activating and T790M Mutants, ErbB2, ErbB4, and VEGFR2, Displays Potent Antitumor Activity Both In Vitro and In Vivo
21. Data from Long Noncoding RNA AB074169 Inhibits Cell Proliferation via Modulation of KHSRP-Mediated CDKN1a Expression in Papillary Thyroid Carcinoma
22. Data from Intratumoral Expression of Mature Human Neutrophil Peptide-1 Mediates Antitumor Immunity in Mice
23. Table S1 from Long Noncoding RNA AB074169 Inhibits Cell Proliferation via Modulation of KHSRP-Mediated CDKN1a Expression in Papillary Thyroid Carcinoma
24. Supplementary Data from Intratumoral Expression of Mature Human Neutrophil Peptide-1 Mediates Antitumor Immunity in Mice
25. Figure S1-S4 from Long Noncoding RNA AB074169 Inhibits Cell Proliferation via Modulation of KHSRP-Mediated CDKN1a Expression in Papillary Thyroid Carcinoma
26. MicroRNA-Modulated Apoptotic and Autophagic Signaling Networks in Cancer
27. Correction: Inhibition of Stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis
28. RNA-Seq profiling of circular RNA in human lung adenocarcinoma and squamous cell carcinoma
29. Circular RNA F-circSR derived from SLC34A2-ROS1 fusion gene promotes cell migration in non-small cell lung cancer
30. Exosomal tRNA-derived small RNA as a promising biomarker for cancer diagnosis
31. Author Correction to: TRIM29 negatively controls antiviral immune response through targeting STING for degradation
32. The effect of chronic stress on anti-angiogenesis of sunitinib in colorectal cancer models
33. Circular RNA F-circEA produced from EML4-ALK fusion gene as a novel liquid biopsy biomarker for non-small cell lung cancer
34. Non-viral and viral delivery systems for CRISPR-Cas9 technology in the biomedical field
35. Recent development of poly(ethylene glycol)-cholesterol conjugates as drug delivery systems
36. Intermedin Enlarges the Vascular Lumen by Inducing the Quiescent Endothelial Cell Proliferation
37. Recent Advances of Nanostructures in Antimicrobial Therapy
38. Circular RNA F-circEA-2a derived from EML4-ALK fusion gene promotes cell migration and invasion in non-small cell lung cancer
39. MicroRNA-214 promotes hepatic stellate cell activation and liver fibrosis by suppressing Sufu expression
40. TRIM29 negatively controls antiviral immune response through targeting STING for degradation
41. MicroRNA-302b negatively regulates IL-1β production in response to MSU crystals by targeting IRAK4 and EphA2
42. Folate-linked lipoplexes for short hairpin RNA targeting claudin-3 delivery in ovarian cancer xenografts
43. Impaired XPO5 function leads to transportation failure of microRNA precursor
44. Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors
45. Establishing guidelines for CAR-T cells: challenges and considerations
46. CXCL13 as a Novel Immune Checkpoint for Regulatory B Cells and Its Role in Tumor Metastasis
47. Cellular Immunotherapy for Carcinoma Using Genetically Modified EGFR-Specific T Lymphocytes
48. Gene therapy research in Asia
49. Irradiated VEGF164-modified tumor cell vaccine protected mice from the parental tumor challenge
50. Down-regulation of MFG-E8 by RNA interference combined with doxorubicin triggers melanoma destruction
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.